Home › Research › Digital health tools
Digital biomarkers in early Alzheimer's disease from wearable or portable technology: A scoping review
Mathias Holsey Gramkow, Helena Sophia Gleerup, Anja Hviid Simonsen, Gunhild Waldemar, Kristian Steen Frederiksen. Journal of the Neurological Sciences, 2026-01-06
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
After deduplication and screening of 8893 records, we included 109 studies describing a wide array of wearable or portable DHTs that obtained digital biomarkers. The study population consisted of 3019 individuals with MCI due to AD (54 % female, weighted mean age 73 years), and 1942 individuals with mild AD (55 % female, weighted mean age 73 years). The most studied biomarkers were rest/activity (39 %), speech (17 %), and gait (14 %), with most studies focusing on one domain. Few studies reported outcomes associated with diagnosis (16 %) and prognosis (3 %). We identified a growing evidence base investigating digital biomarkers in early AD. There is a paucity of studies examining diagnostic and prognostic properties, representing a knowledge gap. This overview may help to guide future research efforts to bridge the gap between the development and clinical implementation of digital biomarkers in early Alzheimer's disease.
What this study adds
Evidence grade: Low
The record lists 109 participants. This scoping review of 109 studies found a growing evidence base for wearable or portable digital biomarkers in early Alzheimer's disease, most commonly rest/activity, speech, and gait. However, few studies reported outcomes associated with diagnosis or prognosis, representing a knowledge gap, and this does not treat, cure, or prevent Alzheimer's disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Gramkow, M. H., Gleerup, H. S., Simonsen, A. H., Waldemar, G., & Frederiksen, K. S. (2026). Digital biomarkers in early Alzheimer's disease from wearable or portable technology: A scoping review. Journal of the Neurological Sciences. https://doi.org/10.1016/j.jns.2026.125734
Vancouver
Gramkow MH, Gleerup HS, Simonsen AH, Waldemar G, Frederiksen KS. Digital biomarkers in early Alzheimer's disease from wearable or portable technology: A scoping review. Journal of the Neurological Sciences. 2026. doi:10.1016/j.jns.2026.125734. PMID: 41518717.
BibTeX
@article{gramkow2026-41518717,
author = {Gramkow, Mathias Holsey and Gleerup, Helena Sophia and Simonsen, Anja Hviid and Waldemar, Gunhild and Frederiksen, Kristian Steen},
title = {{Digital biomarkers in early Alzheimer's disease from wearable or portable technology: A scoping review}},
journal = {Journal of the Neurological Sciences},
year = {2026},
doi = {10.1016/j.jns.2026.125734},
pmid = {41518717},
url = {https://doi.org/10.1016/j.jns.2026.125734}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- After deduplication and screening of 8893 records, we included 109 studies describing a wide array of wearable or portable DHTs that obtained digital biomarkers.
- The study population consisted of 3019 individuals with MCI due to AD (54 % female, weighted mean age 73 years), and 1942 individuals with mild AD (55 % female, weighted mean age 73 years).
- The most studied biomarkers were rest/activity (39 %), speech (17 %), and gait (14 %), with most studies focusing on one domain.
- Few studies reported outcomes associated with diagnosis (16 %) and prognosis (3 %).
- We identified a growing evidence base investigating digital biomarkers in early AD.
Why it matters
This scoping review of 109 studies found a growing evidence base for wearable or portable digital biomarkers in early Alzheimer's disease, most commonly rest/activity, speech, and gait. However, few studies reported outcomes associated with diagnosis or prognosis, representing a knowledge gap, and this does not treat, cure, or prevent Alzheimer's disease.
New to this subject? Start with our plain-English guide: Digital health →
Study details
- Participants109
- Evidence strengthLow
How this study scored 49/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of the Neurological Sciences) |
| Journal's citation record | 2 / 4 | Journal of the Neurological Sciences: journal h-index 233 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 2 / 4 | 109 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 6 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 3.0 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 5 / 6 | Cited 28.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 1 / 4 | Cited 6 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Kristian Steen Frederiksen: h-index 37 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Copenhagen: institution h-index 1,378 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41518717) |
| Free to read | 2 / 2 | Free to read |
| Total | 49 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1016/j.jns.2026.125734
- PubMed: 41518717
- Original source →
- Free full text: Journal of the Neurological Sciences →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 19.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Digital health tools from nearby years
Also in Digital health tools
178 studies in the library are filed under Digital health tools with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Digital health tools hub.